Antipsychotic prescribing before clozapine in a community psychiatric hospital: A case note review

Psychiatria Danubina

Volumn 25, Issue SUPPL.2, 2013, Pages

  Najim, Hellme ^a   Heath, David ^a   Singh, Pranveer ^a  

^a BASILDON HOSPITAL   (United Kingdom)

Author keywords

Clozapine; Schizophrenia

Indexed keywords

CLOZAPINE; RISPERIDONE;

ADULT; AGED; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE DURATION; FEMALE; HUMAN; MALE; MENTAL HOSPITAL; MIDDLE AGED; OUTCOME ASSESSMENT; PRESCRIPTION; RETROSPECTIVE STUDY; SCHIZOPHRENIA; THERAPY DELAY; TREATMENT RESISTANT SCHIZOPHRENIA; YOUNG ADULT;

EID: 84892425899     PISSN: 03535053     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (15)

1. Downs J & Zinkler M: Clozapine national review of postcode prescribing. Psychiatr Bull 2007; 31:384-7.
2. Farooq S & Taylor M: Clozapine: dangerous orphan or neglected friend? Editorial British Journal of Psychiatry: 2011; 198:247-249.
3. Kinon BJ, Kane JM, Johns C et al: Treatment of neuroleptic resistant schizophrenic relapse. Psychopharmacol Bull 1993; 29:309-314.
4. Leucht S, Corves C, Arbter D, Engel RR, Li C & Davis JM: Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis. Lancet 2009; 373:31-41.
5. National Institute for Health and Clinical Excellence. Guidance on the Use of Newer (Atypical) Antipsychotic Drugs for the Treatment of Schizophrenia. Technology Appraisal No. 82. 2009.
6. Nielson J, Dahm M, Lublin H & Talyor D: Psychiatrists attitude towards and knowledge of Clozapine treatment. Journal of Psychopharma 2010; 24:965-971.
7. Rosenheck R, Cramer J, Xu, W et al: A comparison of Clozapine and haloperidol in hospitalised patients with refractory schizophrenia. N Engl J Med 1997; 337:809-815.
8. Schooler NR, Keith SJ, Severe JB et al: Relapse and rehospitalization during maintenance treatment of schizophrenia: the effects of dose reduction and family management. Arch Gen Psychiatry 1997; 54:453-463.
9. Sheachnasaigh Eimear Ni: Poster presentation, United Kingdom Psychiatric Pharmacy Group Conference, October 2005.
10. Szymanski SR, Cannon TD, Gallacher F et al: Course of treatment response in first episode and chronic schizophrenia. Am J Psychiatry 1996; 153:519-525.
11. Taylor D, Young C & Paton C: Prior Antipsychotic Prescribing in Patients currently receiving Clozapine: a case note review. J. Clin Psychiatry 2003; 64:30-34.
12. Taylor D, Shepland G, Laverick G, Bond J & Munro J: Colapine- a survey of patient perception. Psychiatr Bull 2000; 24:450-2.
13. Tiihonen J, Lönnqvist J, Wahlbeck K, Klaukka T, Niskanen L, Tanskanen A & Haukka J: 11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study). The Lancet 2009; 374:620-627.
14. Weissman EM: Antipsychotic prescribing practices in the Veterans Healthcare Administration - New York metropolitan region. Schizophr Bull 2002; 31-42.
15. Wheeler AJ: Treatment pathway and patterns of Clozapine prescribing for schizophrenia in New Zealand. Am Pharmacother 2008; 42:852-60.